Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes.
about
Multicenter Evaluation of the New Abbott RealTime Assays for Quantitative Detection of Human Immunodeficiency Virus Type 1 and Hepatitis C Virus RNAEvaluation of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test and identification of rare polymorphisms potentially affecting assay performanceLarge-scale analysis of the prevalence and geographic distribution of HIV-1 non-B variants in the United StatesNon-M variants of human immunodeficiency virus type 1.Increased genetic diversity of HIV-1 circulating in Hong KongResults of the Abbott RealTime HIV-1 assay for specimens yielding "target not detected" results by the Cobas AmpliPrep/Cobas TaqMan HIV-1 TestCorrection of underquantification of human immunodeficiency virus type 1 load with the second version of the Roche Cobas AmpliPrep/Cobas TaqMan assayPerformance evaluation of the new Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 for quantification of human immunodeficiency virus type 1 RNA.Baseline genotypic and phenotypic susceptibilities of HIV-1 group O to enfuvirtide.Cross-platform analysis of HIV-1 RNA data generated by a multicenter assay validation study with wide geographic representation.Development of real-time PCR array for simultaneous detection of eight human blood-borne viral pathogens.Technical and regulatory shortcomings of the TaqMan version 1 HIV viral load assayGeneration of a recombinant Gag virus-like-particle panel for the evaluation of p24 antigen detection by diagnostic HIV tests.Dynamics of two separate but linked HIV-1 CRF01_AE outbreaks among injection drug users in Stockholm, Sweden, and Helsinki, FinlandComparison of the RealTime HIV-1, COBAS TaqMan 48 v1.0, Easy Q v1.2, and Versant v3.0 assays for determination of HIV-1 viral loads in a cohort of Canadian patients with diverse HIV subtype infections.Comparative evaluation of the performance of the Abbott RealTime HIV-1 assay for measurement of HIV-1 plasma viral load on genetically diverse samples from GreeceCobas ampliprep/cobas TaqMan HIV-1 v2.0 assay: consequences at the cohort level.The significance of HIV 'blips' in resource-limited settings: is it the same? analysis of the treat Asia HIV Observational Database (TAHOD) and the Australian HIV Observational Database (AHOD).Use of reverse-transcriptase-based HIV-1 viral load assessment to confirm low viral loads in newly diagnosed patients in Switzerland.Systematic review of the performance of HIV viral load technologies on plasma samples.Prevalence and resistance mutations of non-B HIV-1 subtypes among immigrants in Southern Spain along the decade 2000-2010.Molecular methods and platforms for infectious diseases testing a review of FDA-approved and cleared assays.A new real-time quantitative PCR for diagnosis and monitoring of HIV-1 group O infection.Performance of the novel Qiagen artus QS-RGQ viral load assays compared to that of the Abbott RealTime system with genetically diversified HIV and hepatitis C Virus plasma specimensDifficulties in diagnosing group o human immunodeficiency virus type 1 acute primary infection.A Multiplex PCR Approach for Detecting Dual Infections and Recombinants Involving Major HIV VariantsHIV-2 diagnosis and quantification in high-risk patients.Comparison of the Abbott m2000 HIV-1 Real-Time and Roche AMPLICOR Monitor v1.5 HIV-1 assays on plasma specimens from Rakai, Uganda.Impact of discrepancies between the Abbott realtime and cobas TaqMan assays for quantification of human immunodeficiency virus type 1 group M non-B subtypes.Comparison of the Abbott Realtime HIV-1 and HCV viral load assays with commercial competitor assays.Antiretroviral drug resistance surveillance among treatment-naive human immunodeficiency virus type 1-infected individuals in Angola: evidence for low level of transmitted drug resistance.Evaluation of the Abbott m2000 RealTime human immunodeficiency virus type 1 (HIV-1) assay for HIV load monitoring in South Africa compared to the Roche Cobas AmpliPrep-Cobas Amplicor, Roche Cobas AmpliPrep-Cobas TaqMan HIV-1, and BioMerieux NucliSENEvaluation of the Abbott investigational use only realtime HIV-1 assay and comparison to the Roche Amplicor HIV-1 monitor test, version 1.5.Census and analysis of persistent false-negative results in serological diagnosis of human immunodeficiency virus type 1 group O infections.Comparative evaluation of the ExaVir Load version 3 reverse transcriptase assay for measurement of human immunodeficiency virus type 1 plasma load.Clinical and resistance consequences of misquantification of plasma and cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) RNA in samples from an HIV-1 subtype G-infected patient.Clinical evaluation of BioPlex 2200 HIV Ag-Ab, an automated screening method providing discrete detection of HIV-1 p24 antigen, HIV-1 antibody, and HIV-2 antibody.Causes and consequences of incomplete HIV RNA suppression in clinical trials.Defining treatment failure in resource-rich settings.Current challenges to viral load testing in the context of emerging genetic diversity of HIV-1.
P2860
Q27480924-4A442F6B-4B76-4701-B799-F5C6D3ED439FQ28286100-A346243A-6DE9-49FF-B96C-E73A273FAAD0Q28675438-AF40F29C-60AF-4A67-8141-EE2FDD7B57D6Q30432689-94CD8E36-8D2C-4F9A-84CD-1EF3748278C1Q33680950-B7CE4041-9DF0-44CF-9F9A-E9D742058D70Q33704727-4349BD68-7A9E-468A-9B9A-EA540A58D160Q33769491-9DD71137-30F3-4381-ADBE-7FF23C56D964Q33769514-ECC9E3EF-F534-432C-84CC-5C749BF58C29Q34108713-76CB1CCA-A239-4842-B741-689D275AA6D1Q34301929-45A3F4DE-083F-4091-ABAD-3B5E0B18DFA3Q34389449-96D73C29-AC50-4D90-8E55-5DA88841363EQ34399511-06BE4E8C-1982-4CA1-8305-9A280A0E5652Q34400923-0F496688-B19E-4BEA-8A9E-E863E85EBB17Q34458028-11CB21D4-0BCC-4D6E-B28F-C518532EA929Q34487510-056E70CF-95CE-453F-9015-981C85489162Q34547246-2DF380D1-475B-43E9-A122-E888205DC2F2Q34983777-06A9C971-5F05-4E51-8437-D1B931DC0ADCQ35091354-C4B8F586-7730-463D-A602-28D24E0A8647Q35093899-1F022BAD-6BD3-4B0F-9AF9-47AC8F12CFE0Q35099443-FC81A0C7-5F8D-44B2-90DD-6A4FE8F51266Q35206389-8E3F93D0-48A2-4C75-AEF9-6BF2BBF83636Q35356381-82B3464B-9C70-4003-8B8D-12F06B691059Q35807096-72EC35D6-BC88-44E5-8249-C1FEB66643F4Q36022867-09D5C4E8-E842-4798-96E2-0397D31DB53AQ36747558-EDEFEC64-A70D-4D79-AE81-385C403561DFQ36834771-55027E08-E868-48F5-90D0-3B6DB3AA0648Q36862541-69680A38-1EBF-4339-AF83-B8BB00079487Q37050729-E7FB542C-039F-4F31-B2C4-0A3E413C3E2FQ37191559-B19D262D-5CFD-4E7D-AFB6-B31192E2BCA5Q37206232-949725F4-DBDF-40AD-A94A-D662AC195CA2Q37247746-370388CE-0F6D-42DD-BB9C-2138AC7A2EE2Q37256264-2D9E1923-8DE8-4C33-8502-CD34E6654886Q37261877-25C49DEA-23B8-4C23-A902-C9C814F0830EQ37333651-05796C1C-6215-43E6-84F9-DDA5792AAA02Q37374897-62B9B20C-C193-4424-B4A9-10C5B4AC02F4Q37410496-1A7193FC-51E4-4AD8-9C7C-8FA58AA1A0CAQ37546640-0BC19701-E88C-41FC-B0EC-96CC3AC1D3E1Q37631282-9A56CE98-5E90-4BCC-8DDA-77E9AC865C68Q37667776-4E8BF4A7-C2E6-4108-BDF9-24996EDD0971Q38088726-18F660BE-C4E9-4919-A252-7A13BA91A4B4
P2860
Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Evaluation of the Roche Cobas ...... on systems for HIV-1 subtypes.
@en
Evaluation of the Roche Cobas ...... on systems for HIV-1 subtypes.
@nl
type
label
Evaluation of the Roche Cobas ...... on systems for HIV-1 subtypes.
@en
Evaluation of the Roche Cobas ...... on systems for HIV-1 subtypes.
@nl
prefLabel
Evaluation of the Roche Cobas ...... on systems for HIV-1 subtypes.
@en
Evaluation of the Roche Cobas ...... on systems for HIV-1 subtypes.
@nl
P2093
P1476
Evaluation of the Roche Cobas ...... on systems for HIV-1 subtypes.
@en
P2093
Annick Ruffault
François Simon
Loic Chartier
Marie Gueudin
Marie Paule Schmitt
Muriel Vray
Thomas Bourlet
Véronique Lemée
P304
P356
10.1097/QAI.0B013E31803260DF
P407
P577
2007-04-01T00:00:00Z